The mouse is the most commonly used species in preclinical research, and isolated tissues are used to study slow waves from the interstitial cells of Cajal-smooth muscle syncytium of the gastrointestinal tract. The aim of this study was to establish a radiotelemetric technique in awake mice to record gastric myoelectric activity from the antrum to gain insight into the effects of endogenous modulatory systems on slow waves. Under general anaesthesia, two biopotential wires from a telemetry transmitter were sutured into the antrum of male ICR (imprinting control region) mice. The animals were allowed 1 week to recover from surgery before the I.P. administration of drugs to stimulate or inhibit slow waves. The basal dominant frequency of slow waves was 6.96 ± 0.43 c.p.m., and the percentages of power in the bradygastric, normogastric and tachygastric ranges were 6.89 ± 0.98, 37.32 ± 1.72 and 34.38 ± 0.77%, respectively (n = 74). Nicotine at 1 mg kg −1 increased normogastric power, but at 3 mg kg −1 it increased bradygastric power (P < 0.05). Metoclopramide at 10 mg kg −1 increased normogastric power; sodium nitroprusside at 10 mg kg −1 had latent effects on tachygastric power (P < 0.05); and L-NAME at 10 mg kg −1 had no effect (P > 0.05). Nicotine and bethanechol also caused varying degrees of hypothermia (>1 • C reductions; P < 0.05). In conclusion, radiotelemetry can be used to record slow waves from awake, freely moving mice. In light of our findings, we recommend that studies assessing slow waves should also assess body temperature simultaneously.
INTRODUCTION
Gastric myoelectrical activity (GMA) comprises low-frequency slow waves and neuronal spike activity (Chang, 2005; Koch & Stern, 1973; Verhagen, 2016) . The slow waves can be isolated by digital filtering and are presumed to arise from the interstitial cells of Cajal (ICCs)-smooth muscle syncytium (Koch & Stern, 1973) . The ICCs are pacemaker cells, which spontaneously depolarize to provide the underlying current for the direction and velocity of peristaltic waves (Sanders, Ward, & Koh, 2006) . The function of ICCs and smooth muscle can be modulated by the autonomic and enteric nervous systems and by the action of hormones and local mediators (Huizinga et al., 2011) . It is believed that several disorders of gastrointestinal motility are related to problems c 2018 The Authors. Experimental Physiology c 2018 The Physiological Society caused by dysfunction in one or more of these elements (Tse, Lai, Yeo, Tse, & Wong, 2009) .
It is generally accepted that cholinergic nerves provide the main excitatory input to determine the excitability of smooth muscle cells in the gastrointestinal tract, whereas sympathetic nerves and/or nitric oxide (NO) provides the major inhibitory control (Browning & Travagli, 2014) . Data generated from isolated tissues or cultured ICCs from mice indicate that similar control mechanisms impinge on slow waves (Sanders, Koh, & Ward, 1992) . For example, the mixed muscarinic/nicotinic agonist, carbachol, has positive chronotropic effects (Forrest, Ordog, & Sanders, 2006) , and sodium nitroprusside, an NO donor, induces hyperpolarization and inhibits slow waves (Koh et al., 2004; Zhu & Huizinga, 2013) .
Experimental Physiology. 2018;103:827-837.
wileyonlinelibrary.com/journal/eph
New Findings
• What is the central question of this study?
Gastric slow waves originating from the interstitial cells of Cajal-smooth muscle syncytium are usually studied in culture or in tissue segments, but nobody has described recordings of slow waves from awake, freely moving mice.
Can radiotelemetry be used to record slow waves, and do they respond predictably to drug treatment?
• What is the main finding and its importance?
Radiotelemetry can be used to record slow waves from awake, freely moving mice, permitting an examination of drug actions in vivo, which is crucial to drug discovery projects for characterizing the effects of drugs and metabolites on gastrointestinal function.
Gastroenterologists use electrogastrography, a technique in which electrodes are placed on the skin above the stomach, to investigate abnormalities in gastric slow waves (Sanmiguel, Mintchev, & Bowes, 2014; Yin & Chen, 2015) . In contrast, most preclinical research and the current understanding of the mechanisms involved in the control of slow waves are based on isolated tissue segments and/or cultures of ICCs from the mouse, including various knockout strains (Sanders et al., 1992 involves a modulation of output (e.g. neuronal or hormonal) from the CNS to modify the activity of the ICCs-smooth muscle syncytium. It is also possible that the function of the ICCs-smooth muscle syncytium could be altered secondary to other factors in the periphery (e.g. vasoconstriction) that would not normally be understood from isolated tissue/cell studies. As yet, there have been no recordings of slow waves from awake, freely moving mice. Therefore, the aim of the present study was to establish and characterize the criteria for recording and analysing gastric slow-wave activity in awake, freely moving ICR (imprinting control region) mice, the most commonly used species in biomedical research (J. E. Kim, Nam, Cho, Kim, & Hwang, 2017) . It was hoped that these fundamental studies would provide information on gastric function relevant to the discovery of new drugs for the treatment of gastrointestinal diseases.
To study the effect of excitation on slow waves, we used bethanechol to activate muscarinic receptors non-selectively (Jakubik, Bacakova, El-Fakahany, & Tucek, 1997) . To study the effect of inhibition, we used sodium nitroprusside and compared this with the effect of the nitric oxide synthase (NOS) inhibitor (Grossi & D'Angelo, 2005) , N G -nitro-L-arginine methyl ester (L-NAME; Pfeiffer, Leopold, Schmidt, Brunner, & Mayer, 1999) . Nicotine was selected to activate nicotinic receptors at ganglia (Barlow, Bowman, Ison, & McQueen, 1974 ), which we hypothesized would have a mixed effect on slow waves via the concurrent activation of the autonomic and enteric systems (both excitatory and inhibitory systems). We also studied the action of metoclopramide, a known prokinetic used clinically in the treatment of functional dyspepsia, with a mechanism of action involving the stimulation of 5-hydroxytryptamine 4 (5-HT 4 ) receptors (releasing acetylcholine from enteric nerves) and the blocking of dopamine D 2 and 5-HT 3 receptors (Lee & Kuo, 2002; Quigley, 1996) .
We were also able to measure the temperature of the animals non-invasively because the telemetry transmitter was fitted with a temperature sensor. We considered this to be important because ICCs are known to express temperature-sensitive channels (Suzuki & Hirst, 2009; Ward & Sanders, 2005) .
METHODS

Ethical approval
All experiments were conducted under the authority of a licence provided by the Government of the Hong Kong SAR and permission from the Animal Experimentation Ethics Committee, the Chinese University of Hong Kong (Ethics approval reference no. 15-130-MIS), and under the principles and regulations described in the editorial by Grundy (2015) .
Animals
Three-month-old male imprinting control region (ICR) mice (weighing 30-40 g) obtained from the Laboratory Animal Services Centre, the Chinese University of Hong Kong, were used in the study. All mice were housed in groups of eight to 10 in a temperature-controlled room (24.0 ± 1 • C), under artificial lighting, with a light cycle from 06.00 to 18.00 h before the experiments, and relative humidity at 50 ± 5%.
The bedding of the cages consisted of wood shavings. All animals were allowed free access to water and food ad libitum.
Transmitter implantation in mice
We have previously reported techniques for the implantation of radiotelemetry transmitters to record GMA in both Asian house musk shrews (Suncus murinus) and ferrets (Percie du Sert, Chu, Wai, Rudd, & Andrews, 1999 . Briefly, mice were injected S.C.
with buprenorphine (0.05 mg kg −1 ) as a pre-operative analgesic.
After 15 min, general anaesthesia was induced and maintained with inhalation of isoflurane (2.5% isoflurane in 0.8% oxygen) using an (2 mg kg −1 , S.C.) was given on the day of surgery and daily for 2 days post-surgery to provide antibiotic cover against potential infection.
Recovery was unremarkable; no adverse effects were observed, and the wounds healed within a week.
Experimental design
The mice were housed individually from the day of surgery until the end of the experiment; food and water were available at all times.
A Dataquest R ART telemetry system from DSI was used to acquire telemetry data from the implants. The telemetry signals were recorded via a receiver (PhysioTel R RPC-1 receiver for plastic cages) placed under the cages. The receivers were connected to a computer via a matrix (Dataquest ART Data Exchange Matrix). Data were recorded with Dataquest Acquisition software (DQ ART version 5.0). Seven days after surgery, 2 h basal GMA and body temperature recordings were obtained before the I.P. administration of drugs (nicotine, 0.1, 1.0 and 3.0 mg kg −1 ; bethanechol, 6 mg kg −1 ; sodium nitroprusside, 0.5 mg kg −1 ; L-NAME, 10 mg kg −1 ; metoclopramide, 10 mg kg −1 ) or vehicle (saline, 2 ml kg −1 ). Recordings then continued for a further 6 h. There were five different experiments, and they were run independently using a randomized-block design. No animals were reused. The telemetry system was designed to record up to eight mice simultaneously. Recordings were made in a housing chamber that was shielded with stainless steel and had a direct current control system for lighting (0.17 lx) and air flow; the chamber was also insulated against outside noise.
Drugs
At the end of experiments, the mice were killed by I. Co. LLC. Other than sodium nitroprusside, which was given I.P. at 1 ml kg −1 , all of the drugs were dissolved in saline and injected I.P. at 2 ml kg −1 .
Analysis of telemetry recordings
The raw data were sampled at 1 kHz and then digitally filtered using The mean values of 20 min sections throughout 6 h recording periods (1 h of baseline and 5 h of treatment) were computed. To investigate the effect of the drugs on GMA, the DFs and the percentage powers of the brady-, normo-and tachygastric ranges were compared between different treatment groups.
Analysis of the power spectrum
Statistical analysis
To evaluate the overall effects of the drugs and vehicle on gastric slow waves and body temperature, the data for the treatment groups were compared using a repeated-measures two-way ANOVA with Fisher's LSD post hoc tests (factors: treatment and time). A P value of <0.05 was considered statistically significant. All statistical analyses were performed using GraphPad Prism version 5.0 (GraphPad Software, San Diego, CA, USA). All data are reported as means ± SD.
Pooled data represent all baseline data recorded during each set of experiments.
RESULTS
Characteristics of basal gastric myoelectric activity and body temperature
The recordings of GMA that we obtained were relatively clean and did not appear to have movement artefacts. After filtering the raw signals 
Effect of nicotine on gastric myoelectric activity and body temperature
Before the administration of nicotine (0.1-3.0 mg kg −1 ) or saline The body temperature of the metoclopramide-treated animals was not significantly different from that of the saline-treated control animals (P > 0.05; Figure 4 ).
Effects of sodium nitroprusside and L-NAME on gastric slow-wave activity and body temperature
In the experiments involving sodium nitroprusside, the baseline DF ranged from 5.4 to 9.0 c.p.m.; the percentage power of bradygastria ranged from 1.46 to 13.19% (5.97 ± 1.08%, pooled data, n = 9), the percentage power of normogastria ranged from 20.76 to 58.09%
(39.43 ± 3.54%, pooled data, n = 9), and the percentage power of tachygastria ranged from 21.39 to 46.09% (34.24 ± 2.43%, pooled data, n = 9). Baseline temperature was 35.11 ± 1.95 • C (pooled data, n = 9).
At 120 min, the animals treated with sodium nitroprusside had 3% less power in the bradygastric range and a 5.5% increase in power in the tachygastric range, when compared with the vehicle-treated animals ( Figure 5 ). The sodium nitroprusside-treated animals also appeared to have a ∼1 • C lower body temperature than the vehicle-treated animals, but this was transient and seen only at 20 min and was not significantly different from their own baseline. The observed difference might therefore be irrelevant, particularly as the control animals experienced an increase in temperature at the corresponding time point (P < 0.05; Figure 5 ).
In the experiments involving L-NAME, the baseline DF ranged from 5.4 to 9.0 c.p.m.; the percentage power of bradygastria ranged from 1.10 to 19.22% (7.65 ± 1.38%, pooled data, n = 14), the percentage power of normogastria ranged from 13.39 to 72.71% (37.07 ± 5.01%, pooled data, n = 14), and the percentage power of tachygastria ranged from 12.33 to 53.43% (35.64 ± 3.29%, pooled data, n = 14). The baseline temperature was 35.08 ± 0.22 • C (pooled data, n = 14). The administration of L-NAME or saline (2 ml kg −1 ) did not modify any of the parameters of GMA or temperature during the 4 h recording period (P > 0.05; see Figure 5 ).
DISCUSSION
Interstitial cells of Cajal and slow waves have been studied extensively, both using isolated tissue segments and in culture. Most studies have used mouse-derived ICCs-smooth muscle syncytium. Although
ICCs have an inherent rhythmicity, their function is modulated by the autonomic and enteric systems and a variety of hormones and/or mediators (Huizinga et al., 2011) . The complexity of the responsiveness of in vivo ICCs-smooth muscle syncytium to drugs is therefore dependent on direct and indirect mechanisms, the latter of which cannot be predicted from tissue or culture systems alone.
To the best of our knowledge, the characteristics of GMA and gastric slow waves have not been established previously in awake ICR mice using electrogastrographic techniques. Our studies used a radiotelemetric recording and analysis protocol, similar to our pre- Data represent the means ± SD of between four and 10 animals. Significant differences relative to the vehicle group are shown as * P < 0.05, ** P < 0.01 and *** P < 0.001 (two-way ANOVA, followed by Fisher's LSD post hoc tests)
whereas our results indicate that drug action can contract or relax smooth muscle, which might affect the characteristics of slow waves, because ICCs can be modulated by stretch (Won, Sanders, & Ward, 2001 ).
We decided initially to study the actions of nicotine on gastric slow waves by administering nicotine to stimulate the cholinergic nicotinic receptors located on enteric ganglia. Nicotinic receptors are not present on ICCs, so our expectation was that nicotine would stimulate the release of a mix of excitatory and inhibitory mediators to affect slow waves indirectly; we also expected to observe an indirect excitatory action to contract smooth muscle (Lecci, Santicioli, & Maggi, 2000) .
Nicotine caused a dose-related decrease in DF. At a dose of 1 mg kg −1 , it increased the percentage power of normogastria, but at the highest dose (3 mg kg −1 ), it increased the percentage of bradygastric power and reduced tachygastric power.
The effect of nicotine at lower doses was as predicted and might indicate excitatory input to ICCs. However, at higher doses inhibitory mediators of ICC function may have exerted dominant actions, regardless of whether excitatory mediators had also been released. Acetylcholine is a major endogenous excitatory mediator of ICCs, and in isolated tissue systems it causes an increase in slowwave frequency (Ordog, Ward, & Sanders, 1975) , as does electrical field stimulation; low-frequency stimulation is blocked by atropine and the muscarinic M 3 receptor antagonist, 4-diphenylacetoxy-Nmethylpiperidine methiodide, but high-frequency stimulation, which also increases slow-wave frequency, additionally involves tachykinin NK 1 and NK 2 receptors (Forrest et al., 2006) . The chronotropic effects of acetylcholine on slow waves appear to be mimicked by carbachol, a nicotinic/muscarinic receptor agonist, in cultured ICCs, but not by pilocarpine, a muscarinic M 1 /M 3 receptor agonist, or MCN-A343, an Data represent the means ± SD of between four and eight animals. Significant differences relative to the vehicle group are shown as * P < 0.05 (twoway ANOVA, followed by Fisher's LSD post hoc tests)
L-NAME M 1 /M 4 -selective agonist (Figueroa, Griffin, & Ehlert, 2009; T. W. Kim, Koh, Ordog, Ward, & Sanders, 2003) . Molecular studies have identified M 2 and M 3 receptors in isolated ICCs (Grider, 2000) .
In our studies, nicotine also presumably activated nicotinic receptors in the adrenal medulla to stimulate the release of adrenaline, which is known from experimentation in rabbits to inhibit contractile/mechanical activity in the gastrointestinal tract (Gray, 1964) .
In dogs, nicotine also decreases gastric antral contractility through the release of catecholamines Carlson, Ruddon, Hug, Schmiege, & Bass, 1970) . It has been suggested that the action of nicotine at higher doses is inhibitory and mediated via the adrenal glands and sympathetic ganglia. Nitric oxide and vasoactive intestinal polypeptide, the dominant inhibitory non-adrenergic, noncholinergic (NANC) neuromodulators in the enteric nervous system, may also be involved in regulating gastric slow waves (Curro & Preziosi, 1997) . We initially hypothesized that the administration of the non-selective muscarinic receptor agonist, bethanechol, which has no affinity for nicotinic receptors, would increase the DF and/or produce an increase in the percentage power of normogastria/tachygastria; it is known to contract isolated gastrointestinal tissue sections (Takeyasu et al., 1999) . However, no significant differences in any of the GMA parameters that we recorded were found. This is difficult to explain.
As bethanechol caused hypothermia, we speculate that the reduction in temperature counteracted the effects that we were expecting to observe. Indeed, in dogs, bethanechol decreased the DF significantly, but temperature was not measured (Chen, Xing, & Chen, 2009 ). In our studies, baseline recordings of GMA made over a narrow temperature range were not correlated with body temperature. However, larger changes in temperature (26-40 • C) are known to be correlated with changes in DF; the effect of reduced temperature impacts on the calcium dynamics underlying pacemaker potentials via effects through metabolically related events and temperature-sensitive channels (Kito & Suzuki, 2007) . Our hypothesis might fit with the profile of nicotine, as a ∼3.5 • C reduction of body temperature favoured an inhibitory action that reduced DF and increased the percentage of bradygastric power.
The mechanisms by which nicotine and bethanechol cause hypothermia and affect GMA may be complex. The nicotinic receptor stimulation in the in vivo situation reported here is not necessarily restricted to the enteric system; it would also activate nicotinic receptors in the autonomic ganglia and the adrenal medulla and could be expected to release a number of mediators, including noradrenaline, acetylcholine and adrenaline, plus a range of co-stored transmitters/mediators; there should also be an action to activate receptors in the hypothalamus, which is also involved in thermoregulation (Knox, Campbell, & Lomax, 2007) . Bethanechol would mimic the effect of acetylcholine at muscarinic receptors to dilate vascular beds, resulting in heat loss (Berard, Boucand, Depassio, & Fyon, 1989) ;
there would also be a range of other biological actions (for a review, see Silvette, Hoff, Larson, & Haag, 2011) . Intestinal slow-wave frequency in ICC culture appears to be positively correlated with temperature (Suzuki & Hirst, 2009; Ward & Sanders, 2005) , and this can also be seen in vivo after the ingestion of water at different temperatures (Koch & Stern, 1973) .
We expected that metoclopramide would be more selective in its effect on GMA than nicotine or bethanechol. Its gastric prokinetic action is purported to involve a release of acetylcholine from enteric nerves through the activation of 5-HT 4 receptors (Lee & Kuo, 2002 ).
This mechanism is highly relevant to the action of metoclopramide to reduce the pressure threshold for peristalsis, which also involves the release of acetylcholine at the enteric-smooth muscle interface (Okwuasaba & Hamilton, 2010) , although acetylcholine released here may not necessarily reach ICCs (Worth et al., 2005) . However antagonists are necessary to resolve the mechanism fully. Certainly, the data we expect on ICCs with any drug need also to be balanced against other effects that are necessarily expected after distribution to other relevant sites in the body that may directly or indirectly affect the DF and other slow-wave parameters. During our experiments, no change in body temperature was seen after metoclopramide administration, and in rats metoclopramide does not alter rectal temperature (Ahtee, 1975) , making our data easier to interpret.
Nitric oxide is well known as an endothelium-derived relaxant factor, but it may also be released from enteric nerves (Sanders & Ward, 2015) . We used sodium nitroprusside as an NO donor because it has been shown to decrease the frequency of slow waves whilst causing a degree of hyperpolarization and inhibiting the slow-wave plateau of canine gastric tissues in vitro (E. P. Burke, Gerthoffer, Sanders, & Publicover, 1996) . Sodium nitroprusside did not affect slowwave frequency (although it did reduce the amplitude) modulated by transmural nerve stimulation in isolated corpus tissue obtained from guinea-pigs; this approach was used to facilitate enteric nerves perceivably to release endogenous mediators to regulate ICC function (Tanaka, Domae, Hashitani, & Suzuki, 1979) . Our results do not show a convincing effect of sodium nitroprusside on body temperature, whereas a previous report indicated that sublethal doses (10 times higher than used in the present studies) can induce hypothermia (D.
H. Burke & O'Hara, 1977) . It is possible that higher doses of sodium nitroprusside could affect ICC functioning indirectly by temperature homeostasis.
We followed our sodium nitroprusside studies by using L-NAME to inhibit endogenous NO synthesis (Pfeiffer et al., 1999) . L-NAME did not alter any of the gastric slow-wave parameters that we measured, which is consistent with canine data (Sun, Hou, & Chen, 1962) . It is possible, therefore, that there is no basal tone of NO on ICC, which is consistent with the failure of sodium nitroprusside to affect GMA.
Furthermore, our studies showed that L-NAME did not modulate body temperature, which is consistent with the results of studies using rats (Perotti, Nogueira, Antunes-Rodrigues, & Carnio, 2010) .
Conclusions
In summary, we established a radiotelemetric technique in the mouse to record gastric myoelectric activity from the antrum. The
ICCs-smooth muscle syncytium produces an underlying current that appears to be modulated by nicotine, although the mechanism is presumed to be indirect and involves an increase in normogastric power at low doses and a shift to bradygastria at higher doses.
Bethanechol, which we expected to increase normogastria or cause tachygastria, did not have obvious effects; the effects of bethanechol and high-dose nicotine might have been masked by hypothermia.
Conversely, sodium nitroprusside was expected to be inhibitory, but if anything, it had delayed effects that could be taken as excitatory, and NO itself does not appear to have a tonic role on GMA, because L-NAME had no effect. In contrast, metoclopramide did increase normogastria, which might be consistent with its known prokinetic action, although there was a corresponding decrease in DF. Our results suggest that the effects that we observed on slow waves recorded from the stomach may be influenced by drugs that affect temperature and contractile state, and these effects should be considered when interpreting the effects on gastric function of drugs that simultaneously affect thermoregulation and motility. In light of our findings, we recommend that all clinical studies assessing slow waves by EGG also simultaneously assess temperature.
